ADAM17 and cancer: We measured the enzymatic activity of ADAM17 in these cell lines, and found that ADAM17 activity as well as mRNA expression increased after gemcitabine treatment in cancer cell lines (Fig. 1G,H, Supplementary Fig. 1C,D).